PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide
- PMID: 14704790
- DOI: 10.1038/nm977
PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide
Abstract
Platelet-activating factor (PAF) induces pulmonary edema and has a key role in acute lung injury (ALI). Here we show that PAF induces pulmonary edema through two mechanisms: acid sphingomyelinase (ASM)-dependent production of ceramide, and activation of the cyclooxygenase pathway. Agents that interfere with PAF-induced ceramide synthesis, such as steroids or the xanthogenate D609, attenuate pulmonary edema formation induced by PAF, endotoxin or acid instillation. Our results identify acid sphingomyelinase and ceramide as possible therapeutic targets in acute lung injury.
Comment in
-
Ceramide lances the lungs.Nat Med. 2004 Feb;10(2):130-1. doi: 10.1038/nm0204-130. Nat Med. 2004. PMID: 14760419 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
